Stockreport

Albireo Provides First Quarter 2018 Business Update

Albireo Pharma, Inc.  (ALBO) 
Last albireo pharma, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.albireopharma.com/investor-relations
PDF  First patient enrolled in Phase 3 trial of IBAT inhibitor A4250 in PFIC   Elobixibat in Japan becomes first IBAT inhibitor approved in the world   Management to host [Read more]